Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections; Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 07 Feb 2017 Planned primary completion date changed from 1 Aug 2020 to 1 Apr 2021.
- 07 Feb 2017 Status changed from not yet recruiting to recruiting.